Literature DB >> 8256503

Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins.

A Charbit1, P Martineau, J Ronco, C Leclerc, R Lo-Man, V Michel, D O'Callaghan, M Hofnung.   

Abstract

A peptide comprising residues glu293 to ser334 from the principal neutralization determinant (V3 loop) of the envelope of human immunodeficiency virus type 1 (HIV1 LAVBRU isolate) has been inserted within internal permissive sites of either LamB or MalE, two envelope proteins from Escherichia coli K12. The MalE hybrid protein (MalE133-V3 loop) was stably expressed in the periplasm of Escherichia coli K12, and the V3 loop peptide was detectable on the surface of the native protein by an anti-gp160 monoclonal antibody (mAb 110-A). The disulfide bridge between the two cysteines of the loop was formed. In contrast, genetic coupling to the outer membrane protein LamB did not allow the expression of a stable hybrid protein, and major proteolytic cleavage products of the LamB153-V3 loop were detected by mAb 110-A. The two plasmid-encoded hybrid genes were transferred to an aroA mutant of Salmonella typhimurium. Constitutive expression of the MalE133-V3 loop had no detectable effect on cell growth and on the survival in vivo of the recipient strain. The LamB153-V3 loop was not stably expressed in Salmonella, either in vitro or in vivo. Live recombinant salmonellas expressing MalE-V3 and LamB-V3 loop hybrids were used to immunize mice. The MalE-V3 loop hybrid induced anti-HIV1 envelope antibodies detectable by Western blot and ELISA, while the anti-HIV1 envelope antibodies induced by the LamB-V3 loop hybrid were only detectable by Western blot. In addition, purified MalE-V3 loop hybrid protein was able to stimulate in vitro and induce in vivo a V3 loop-specific T-cell proliferative response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256503     DOI: 10.1016/0264-410x(93)90046-z

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Control by H-2 genes of the Th1 response induced against a foreign antigen expressed by attenuated Salmonella typhimurium.

Authors:  R Lo-Man; P Martineau; E Dériaud; S M Newton; M Jehanno; J M Clément; C Fayolle; M Hofnung; C D Leclerc
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

2.  Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase.

Authors:  J J Lee; K A Sinha; J A Harrison; R D de Hormaeche; G Riveau; R J Pierce; A Capron; R A Wilson; C M Khan
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

3.  Genetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimurium.

Authors:  C Fayolle; D O'Callaghan; P Martineau; A Charbit; J M Clément; M Hofnung; C Leclerc
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

Review 4.  Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines.

Authors:  J Mestecky; S Jackson
Journal:  J Clin Immunol       Date:  1994-09       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.